Cited by 38Computational Drug Discovery MethodsMachine Learning in Materials Sciencevaccines and immunoinformatics approaches

Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds

Open access
Bajorath, Jürgen, Chávez-Hernández, Ana L., Duran-Frigola, Miquel, Fernández-de Gortari, Eli, Gasteiger, Johann, López-López, Edgar, Maggiora, Gerald M., Medina-Franco, José L. +11 more·2022·Journal of Cheminformatics

Published version of a preprint

Abstract

We report the main conclusions of the first Chemoinformatics and Artificial Intelligence Colloquium, Mexico City, June 15–17, 2022. Fifteen lectures were presented during a virtual public event with speakers from industry, academia, and non-for-profit organizations. Twelve hundred and ninety students and academics from more than 60 countries. During the meeting, applications, challenges, and opportunities in drug discovery, de novo drug design, ADME-Tox (absorption, distribution, metabolism, excretion and toxicity) property predictions, organic chemistry, peptides, and antibiotic resistance were discussed. The program along with the recordings of all sessions are freely available at https://www.difacquim.com/english/events/2022-colloquium/ .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13321-022-00661-0

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 86 · Cited by 38

Authors
Bajorath, J., Chávez-Hernández, A. L., Duran-Frigola, M., Fernández-de Gortari, E., Gasteiger, J., López-López, E., Maggiora, G. M., Medina-Franco, J. L., Méndez-Lucio, O., Mestres, J., Miranda-Quintana, R. A., Oprea, T. I., Plisson, F., Prieto-Martínez, F. D., Rodríguez-Pérez, R., Rondón-Villarreal, P., Saldívar-Gonzalez, F. I., Sánchez-Cruz, N., & Valli, M.
Affiliations
  • University of Bonn (DE)
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University of Arizona (US)
  • Universitat Pompeu Fabra (ES)
  • University of Copenhagen (DK)
  • Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (MX)
  • Universidad Nacional Autónoma de México (MX)
  • Novartis Institutes for BioMedical Research (CH)
  • Universidad De Santander (CO)
Venue
Journal of Cheminformatics
Published
2022-12-02
Volume
14
Issue
1
Pages
82-82
ISSN
1758-2946 (ISSN-L)
OpenAlex
W4311104054
Cited by
38
References
86
Citations by year
2026: 2 · 2025: 12 · 2024: 12 · 2023: 10 · 2022: 2
FWCI
4.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Cheminformatics (publishedVersion, cc-by)
  • ChemRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (publishedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
  • OPUS Repository (Kooperativer Bibliotheksverbund Berlin-Brandenburg) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • The Novartis Repository (Novartis) (submittedVersion)
  • Greater South Information System
Funders
Universidad Nacional Autónoma de México
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
cheminformatics, artificial intelligence, drug discovery, de novo drug design, ADMET prediction, organic chemistry, peptides, antibiotic resistance, bioactive compounds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review